Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05172752 · ClinicalTrials.gov registry record · NA

A University-Community Partnership to Reduce Exposure to Disinfection Byproducts In Appalachia

A NA study of Disinfection By-products, sponsored by Anna Hoover.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT05172752 is a NA study of Disinfection By-products that is actively recruiting participants, run by Anna Hoover. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05172752, a NA study of Disinfection By-products, is actively recruiting participants, sponsored by Anna Hoover.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

Appalachian Kentuckians in Martin and Letcher Counties are grappling with a health-threatening drinking water crisis arising from exposures to disinfection by-products (DBPs). DBPs include trihalomethanes (THMs), haloacetic acids (HAAs), chlorate, and other compounds that have been associated with a variety of adverse health effects, including increased risk of bladder cancer and cardiovascular birth defects. This study implements a multi-stakeholder, multi-method approach to improve understanding of, characterize spatial and temporal variations in, and reduce exposure to DBPs in these Appalachian Kentucky counties.

Conditions Studied

Interventions

  • OTHER Citizen Scientist Training Program
  • OTHER Stakeholder Consultation Core Program

Study Locations (1)

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2022-02-25
Est. Completion 2026-07
Phase NA

Sponsor

Anna Hoover

1 total trials

What the Registry Record Tells You About NCT05172752

The ClinicalTrials.gov registry entry for NCT05172752 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Anna Hoover, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Disinfection By-products appearing as the primary indexed condition, and to 2 interventions - of which Citizen Scientist Training Program is the first listed.

NCT05172752 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT05172752 about?

NCT05172752 is a clinical study titled "A University-Community Partnership to Reduce Exposure to Disinfection Byproducts In Appalachia". Appalachian Kentuckians in Martin and Letcher Counties are grappling with a health-threatening drinking water crisis arising from exposures to disinfection by-products (DBPs). DBPs include trihalomethanes (THMs), haloacetic acids (HAAs), chlorate, and other compounds that have been associated with a...

What is the current status of trial NCT05172752?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2022-02-25. Estimated completion is 2026-07.

What conditions does trial NCT05172752 study?

This clinical trial studies the following conditions: Disinfection By-products.

What interventions are being tested in trial NCT05172752?

The interventions under investigation include: Citizen Scientist Training Program (OTHER), Stakeholder Consultation Core Program (OTHER).

Who is sponsoring clinical trial NCT05172752?

This trial is sponsored by Anna Hoover, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05172752 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.